CF
AMED

Cantor Fitzgerald’s Amedisys AMED Stock Holding History

Cantor Fitzgerald’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-13,949
Closed -$1.37M – 376
2025
Q2 		$1.37M Buy
+13,949
New +$1.32M 0.02% 134
2025
Q1 		– Sell
-17,000
Closed -$1.54M – 328
2024
Q4 		$1.54M Buy
+17,000
New +$1.56M 0.03% 75
2024
Q3 		– Sell
-24,250
Closed -$2.23M – 224
2024
Q2 		$2.23M Buy
24,250
+14,043
+138% +$1.3M 0.44% 45
2024
Q1 		$941K Buy
10,207
+4,350
+74% +$408K 0.22% 65
2023
Q4 		$557K Buy
+5,857
New +$547K 0.11% 91

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Cantor Fitzgerald's AMED Position: Q3 2025 in Review

Cantor Fitzgerald sold out of Amedisys (AMED) in Q3 2025, closing a stake of 13,949 shares — an estimated $1.37M sold.

Cantor Fitzgerald first reported a position in AMED in Q4 2023 and held it in 5 quarters. The position peaked at $2.23M in Q2 2024. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Cantor Fitzgerald reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Cantor Fitzgerald sold 13,949 Amedisys shares in Q3 2025, an estimated $1.37M.
  • Cantor Fitzgerald first reported a position in Amedisys in Q4 2023 and held it in 5 quarters.
  • Cantor Fitzgerald's Amedisys position peaked at $2.23M in Q2 2024.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Cantor Fitzgerald's 13F filing for Q3 2025, filed 14 Nov 2025.